1. Home
  2. CERO vs BKYI Comparison

CERO vs BKYI Comparison

Compare CERO & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • BKYI
  • Stock Information
  • Founded
  • CERO 2017
  • BKYI 1993
  • Country
  • CERO United States
  • BKYI United States
  • Employees
  • CERO N/A
  • BKYI N/A
  • Industry
  • CERO
  • BKYI Computer Software: Prepackaged Software
  • Sector
  • CERO
  • BKYI Technology
  • Exchange
  • CERO Nasdaq
  • BKYI Nasdaq
  • Market Cap
  • CERO 3.1M
  • BKYI 2.7M
  • IPO Year
  • CERO N/A
  • BKYI 1997
  • Fundamental
  • Price
  • CERO $0.89
  • BKYI $0.79
  • Analyst Decision
  • CERO Strong Buy
  • BKYI
  • Analyst Count
  • CERO 1
  • BKYI 0
  • Target Price
  • CERO $11.00
  • BKYI N/A
  • AVG Volume (30 Days)
  • CERO 4.4M
  • BKYI 236.6K
  • Earning Date
  • CERO 04-15-2025
  • BKYI 06-13-2025
  • Dividend Yield
  • CERO N/A
  • BKYI N/A
  • EPS Growth
  • CERO N/A
  • BKYI N/A
  • EPS
  • CERO N/A
  • BKYI N/A
  • Revenue
  • CERO N/A
  • BKYI $6,929,571.00
  • Revenue This Year
  • CERO N/A
  • BKYI $25.12
  • Revenue Next Year
  • CERO N/A
  • BKYI N/A
  • P/E Ratio
  • CERO N/A
  • BKYI N/A
  • Revenue Growth
  • CERO N/A
  • BKYI N/A
  • 52 Week Low
  • CERO $0.53
  • BKYI $0.52
  • 52 Week High
  • CERO $171.00
  • BKYI $3.68
  • Technical
  • Relative Strength Index (RSI)
  • CERO 49.91
  • BKYI 47.91
  • Support Level
  • CERO $0.53
  • BKYI $0.65
  • Resistance Level
  • CERO $1.42
  • BKYI $0.75
  • Average True Range (ATR)
  • CERO 0.12
  • BKYI 0.09
  • MACD
  • CERO 0.07
  • BKYI 0.02
  • Stochastic Oscillator
  • CERO 40.19
  • BKYI 78.17

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About BKYI BIO-key International Inc.

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Share on Social Networks: